Patents Assigned to Bioimics AB
  • Patent number: 11130741
    Abstract: The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: September 28, 2021
    Assignee: Bioimics AB
    Inventors: Leif Kirsebom, Ram Shankar Upadhayaya, Raghava Reddy Kethiri, Anders Virtanen
  • Patent number: 7794967
    Abstract: The present invention relates to a method for detection of novel pathogen inhibitors using models of pathogen specific, and metal binding structures/domains representing essential cellular molecules. The method enables identification of inhibitors that bind to any specific RNA molecule or protein that are essential for cell growth, proliferation and differentiation. The invention also relates to a kit for use in the method. Furthermore, the invention relates to use of aminoglycosides in the development of new drugs.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: September 14, 2010
    Assignee: Bioimics AB
    Inventors: Anders Virtanen, Leif Kirsebom